THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 24 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,857,000 | -6.8% | 3,000,000 | 0.0% | 0.02% | -14.3% |
| Q1 2021 | $3,067,000 | +8.2% | 3,000,000 | 0.0% | 0.02% | +5.0% |
| Q4 2020 | $2,835,000 | +7.1% | 3,000,000 | 0.0% | 0.02% | -4.8% |
| Q3 2020 | $2,648,000 | -9.2% | 3,000,000 | 0.0% | 0.02% | -12.5% |
| Q2 2020 | $2,915,000 | -0.4% | 3,000,000 | 0.0% | 0.02% | -7.7% |
| Q1 2020 | $2,927,000 | +42.4% | 3,000,000 | +50.0% | 0.03% | +100.0% |
| Q4 2019 | $2,055,000 | +11.0% | 2,000,000 | 0.0% | 0.01% | +8.3% |
| Q3 2019 | $1,851,000 | +6.7% | 2,000,000 | 0.0% | 0.01% | +9.1% |
| Q2 2019 | $1,735,000 | -10.4% | 2,000,000 | 0.0% | 0.01% | -8.3% |
| Q1 2019 | $1,937,000 | -5.9% | 2,000,000 | 0.0% | 0.01% | -14.3% |
| Q4 2018 | $2,058,000 | -12.6% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $2,356,000 | +18.9% | 2,000,000 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $1,982,000 | -2.1% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $2,024,000 | -7.3% | 2,000,000 | 0.0% | 0.01% | -7.7% |
| Q4 2017 | $2,184,000 | -10.8% | 2,000,000 | 0.0% | 0.01% | -7.1% |
| Q3 2017 | $2,449,000 | -9.3% | 2,000,000 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $2,699,000 | +7.0% | 2,000,000 | 0.0% | 0.02% | +6.7% |
| Q1 2017 | $2,523,000 | +10.9% | 2,000,000 | 0.0% | 0.02% | +15.4% |
| Q4 2016 | $2,274,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|